Your browser doesn't support javascript.
Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments.
Zhang, Eva; Nguyen, Thi H O; Allen, Lilith F; Kedzierski, Lukasz; Rowntree, Louise C; Chang, So Young; Zhang, Wuji; Habel, Jennifer R; Foo, Isabelle J; Menon, Tejas; Mitchell, Jeni; Leong, Rupert W; Bond, Katherine; Williamson, Deborah A; Kedzierska, Katherine; Christensen, Britt.
  • Zhang E; Department of Gastroenterology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Nguyen THO; Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia.
  • Allen LF; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Kedzierski L; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Rowntree LC; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Chang SY; Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Melbourne, Victoria, Australia.
  • Zhang W; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Habel JR; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Foo IJ; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Menon T; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Mitchell J; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Leong RW; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Bond K; Department of Gastroenterology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Williamson DA; Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia.
  • Kedzierska K; Department of Microbiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Christensen B; Victorian Infectious Disease Reference Laboratory (VIDRL), The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Gut ; 2023 Mar 06.
Article in English | MEDLINE | ID: covidwho-2288479
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Year: 2023 Document Type: Article Affiliation country: Gutjnl-2022-329136

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Year: 2023 Document Type: Article Affiliation country: Gutjnl-2022-329136